tiprankstipranks
The Fly

NeoGenomics updates long-term financial plan

NeoGenomics updates long-term financial plan

The company said, “The Long-Range Plan builds upon the successful execution of the previous three years. NeoGenomics (NEO) intends to achieve the following: 12-13% revenue growth annually, including NGS growth of ~25% per year; gross margin expansion of 100-150 bps per year; adjusted EBITDA improvement of 250-300 bps per year; positive cash flow from operations in 2025 and beyond and serving more than 1M patients annually by 2028 and beyond.”

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1